Literature DB >> 7495308

Transfected type II interleukin-1 receptor impairs responsiveness of human keratinocytes to interleukin-1.

P Bossù1, U Visconti, P Ruggiero, G Macchia, M Muda, R Bertini, C Bizzarri, A Colagrande, V Sabbatini, G Maurizi.   

Abstract

Of the two known types of specific receptors for interleukin (IL)-1, the function of the type II IL-1 receptor (IL-1RII) is still elusive. IL-1RII is allegedly devoid of signaling capacity and is therefore thought to act by trapping and inhibiting IL-1. To directly assess the functional role of IL-1RII, a human keratinocyte cell line has been stably transfected with a cDNA coding for IL-1RII, and its responsiveness to IL-1 has been compared with that of nontransfected cells. Parental cells express IL-1RI and are responsive to low doses of IL-1, whereas transfected cells overexpress IL-1RII, both in its membrane and soluble form, and show a dramatically impaired response to IL-1. Selective block of IL-1RII restores the ability of transfected keratinocytes to respond to IL-1, indicating that the overexpressed IL-1RII is in fact uniquely responsible for their refractoriness to IL-1. The main mechanism of unresponsiveness in transfected keratinocytes appears to be the capture and neutralization of IL-1 by the soluble form of IL-1RII.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495308      PMCID: PMC1869949     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  33 in total

1.  Production of IL-6 by keratinocytes. Implications for epidermal inflammation and immunity.

Authors:  T S Kupper; K Min; P Sehgal; H Mizutani; N Birchall; A Ray; L May
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

Review 2.  Interleukin-1 and its biologically related cytokines.

Authors:  C A Dinarello
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

3.  Regulation of interleukin 1 and its receptor in human keratinocytes.

Authors:  R A Blanton; T S Kupper; J K McDougall; S Dower
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor.

Authors:  C G Larsen; A O Anderson; J J Oppenheim; K Matsushima
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

7.  Detection of interleukin-1 receptors in human epidermis. Induction of the type II receptor after organ culture and in psoriasis.

Authors:  R W Groves; L Sherman; H Mizutani; S K Dower; T S Kupper
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

Review 8.  The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

Authors:  F Colotta; S K Dower; J E Sims; A Mantovani
Journal:  Immunol Today       Date:  1994-12

9.  Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.

Authors:  J G Giri; J Wells; S K Dower; C E McCall; R N Guzman; J Slack; T A Bird; K Shanebeck; K H Grabstein; J E Sims
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

10.  Differential binding of IL-1 alpha and IL-1 beta to receptors on B and T cells.

Authors:  G Scapigliati; P Ghiara; M Bartalini; A Tagliabue; D Boraschi
Journal:  FEBS Lett       Date:  1989-01-30       Impact factor: 4.124

View more
  8 in total

1.  Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis.

Authors:  A Akoum; C Jolicoeur; A Kharfi; M Aubé
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.

Authors:  Marina K Roell; Hassan Issafras; Robert J Bauer; Kristen S Michelson; Nerissa Mendoza; Sandra I Vanegas; Lisa M Gross; Paul D Larsen; Daniel H Bedinger; David J Bohmann; Genevieve H Nonet; Naichi Liu; Steve R Lee; Masahisa Handa; Seema S Kantak; Arnold H Horwitz; John J Hunter; Alexander M Owyang; Amer M Mirza; John A Corbin; Mark L White
Journal:  J Biol Chem       Date:  2010-04-21       Impact factor: 5.157

3.  Role of IL-1 beta and 5-HT2 receptors in midbrain periaqueductal gray (PAG) in potentiating defensive rage behavior in cat.

Authors:  Suresh Bhatt; Rekha Bhatt; Steven S Zalcman; Allan Siegel
Journal:  Brain Behav Immun       Date:  2007-09-24       Impact factor: 7.217

4.  Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic Trioxide.

Authors:  Udensi K Udensi; Hari H P Cohly; Barbara E Graham-Evans; Kenneth Ndebele; Natàlia Garcia-Reyero; Bindu Nanduri; Paul B Tchounwou; Raphael D Isokpehi
Journal:  Biomark Insights       Date:  2011-02-08

5.  Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment.

Authors:  Anne M Lewis; Sheelu Varghese; Hui Xu; H Richard Alexander
Journal:  J Transl Med       Date:  2006-11-10       Impact factor: 5.531

6.  Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria.

Authors:  Stefano Porzio; Paola Bossù; Paolo Ruggiero; Diana Boraschi; Aldo Tagliabue
Journal:  BMC Biotechnol       Date:  2004-10-30       Impact factor: 2.563

7.  In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.

Authors:  Susanna Ricci; Giovanni Macchia; Paolo Ruggiero; Tiziana Maggi; Paola Bossù; Li Xu; Donata Medaglini; Aldo Tagliabue; Lennart Hammarström; Gianni Pozzi; Diana Boraschi
Journal:  BMC Biotechnol       Date:  2003-09-17       Impact factor: 2.563

8.  Differences of IL-1β Receptors Expression by Immunocompetent Cells Subsets in Rheumatoid Arthritis.

Authors:  Alina A Alshevskaya; Julia A Lopatnikova; Nadezhda S Shkaruba; Oksana A Chumasova; Aleksey E Sizikov; Aleksander V Karaulov; Vladimir A Kozlov; Sergey V Sennikov
Journal:  Mediators Inflamm       Date:  2015-09-10       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.